Claire Denizot
- Pharmacology top 5%
- Pharmacogenetics and Drug Metabolism 10
- Drug-Induced Hepatotoxicity and Protection 5
- Plant-based Medicinal Research 2
- Oncology top 10%
- Drug Transport and Resistance Mechanisms 23
-
- Pharmacological Effects and Toxicity Studies 16
-
- Adenosine and Purinergic Signaling 3
-
- HIV/AIDS drug development and treatment 3
-
- Liver Disease Diagnosis and Treatment 2
- Co-authors
- Olivier FardelYannick ParmentierMarc Le VéeElodie JouanAbdullah MayatiA MoreauBruno StiegerArnaud Bruyère
- Partner nations
- FranceSwitzerlandGermany
In The Last Decade
Claire Denizot
27 papers receiving 559 citations
Peers
Comparison fields: 5 of 84
- Pharmacology 110
- Oncology 309
- Pediatrics, Perinatology and Child Health 159
- Physiology 21
- Pharmaceutical Science 24
Countries citing papers authored by Claire Denizot
This map shows the geographic impact of Claire Denizot's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Claire Denizot with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Claire Denizot more than expected).
Fields of papers citing papers by Claire Denizot
This network shows the impact of papers produced by Claire Denizot. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Claire Denizot. The network helps show where Claire Denizot may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Claire Denizot, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2024 | 1 | |
| 3 | 2023 | 2 | |
| 4 | 2022 | 25 | |
| 5 | 2021 | 6 | |
| 6 | 2018 | 9 | |
| 7 | 2018 | 22 | |
| 8 | 2018 | 8 | |
| 9 | 2017 | 8 | |
| 10 | 2017 | 23 | |
| 11 | 2017 | 40 | |
| 12 | 2017 | 9 | |
| 13 | 2016 | 21 | |
| 14 | 2016 | 32 | |
| 15 | 2016 | 17 | |
| 16 | 2015 | 32 | |
| 17 | 2015 | 13 | |
| 18 | 2015 | 12 | |
| 19 | 2014 | 6 | |
| 20 | 2005 | 26 |
About Claire Denizot
Claire Denizot is a scholar working on Pharmacology, Oncology and Pediatrics, Perinatology and Child Health, having authored 27 papers that have together received 563 indexed citations. Recurring topics across this work include Drug Transport and Resistance Mechanisms (23 papers), Pharmacological Effects and Toxicity Studies (16 papers), Pharmacogenetics and Drug Metabolism (10 papers), Drug-Induced Hepatotoxicity and Protection (5 papers), Adenosine and Purinergic Signaling (3 papers), HIV/AIDS drug development and treatment (3 papers), Plant-based Medicinal Research (2 papers) and Liver Disease Diagnosis and Treatment (2 papers). The work is most often cited by research in Pharmacology (110 citations), Oncology (309 citations) and Pediatrics, Perinatology and Child Health (159 citations). Claire Denizot has collaborated with scholars based in France, Switzerland and Germany. Frequent co-authors include Olivier Fardel, Yannick Parmentier, Marc Le Vée, Elodie Jouan, Abdullah Mayati, A Moreau, Bruno Stieger, Arnaud Bruyère, Georges Da Violante and Sophie Potin.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.